Main Menu

Professor Clare Turnbull

Team Leader

The alt text
Professor Clare Turnbull uses genetic sequencing technologies to identify and characterise genetic predispositions to testicular, breast and ovarian cancers. The team are investigating ways to optimise ‘next-generation’ sequencing technologies and analyses of these data in order to identify novel cancer predisposition genes. Team: Predisposition Genetics
0208 722 4485 ORCID 0000-0002-1734-5772


Professor Clare Turnbull undertook her preclinical training in Cambridge and qualified in medicine from Oxford University in 1997. She undertook general medical training across hospitals in Oxford and London and specialist training in clinical genetics in London. She completed a Masters degree in Epidemiology at the London School of Hygiene and Tropical Medicine, and a PhD in Genetic Epidemiology and Molecular Genetics at The Institute of Cancer Research.

As well as scientific work at the ICR, Professor Turnbull is a consultant in clinical cancer genetics at The Royal Marsden Hospital. In her clinical role, she evaluates, investigates and manages individuals and families in which the pattern of disease suggests that there may be inherited predisposition to cancer.

She is also involved in developing evidence-based clinical guidance for management of genetic predisposition to cancer for use within and outside the unit. Professor Turnbull is very active in the clinical cancer genetics community across London and nationally, working to improve standards in delivery of care in this field.